News | Clinical Decision Support | December 26, 2019

Change Healthcare Announces CareSelect Imaging Open Access

Provides no-fee access to qualified clinical decision support mechanism to help providers ensure PAMA compliance in advance of deadline

Effective Jan. 1, 2020, new regulations under the Centers for Medicare & Medicaid Services (CMS) Protecting Access to Medicare Act (PAMA) will require physicians to consult a CMS-approved clinical decision support mechanism before ordering advanced imaging exams for fee-for-service Medicare patients

December 26, 2019 — Effective Jan. 1, 2020, new regulations under the Centers for Medicare & Medicaid Services (CMS) Protecting Access to Medicare Act (PAMA) will require physicians to consult a CMS-approved clinical decision support mechanism before ordering advanced imaging exams for fee-for-service Medicare patients. To help providers ensure compliance with this regulation, Change Healthcare announced that all providers can now leverage the CareSelect Imaging Open Access clinical decision support mechanism for no fee.

“Referring providers without decision support integrated into their EHR lack the tools needed to ensure compliance with the new layer of PAMA requirements that go into effect in January,” said Michael Mardini, CEO of National Decision Support Company, a Change Healthcare company. “By providing no-fee access to our interactive, web-based, clinical decision support technology, we’re making it easy for providers to reference and consult against the largest collection of evidence-based, physician-authored imaging criteria currently available to achieve compliance.”

Customers using CareSelect Imaging with Epic, Cerner, Meditech, and other leading EHRs can enable their external, referring providers to consult through CareSelect Imaging Open Access to help ensure PAMA compliance and meet the January deadline. These providers can register for access and consult Appropriate Use Criteria (AUC) using Open Access. No software or hardware investment is required. Providers can register for access and help ensure their advanced imaging orders are PAMA-compliant by logging onto the CareSelect Imaging Open Access portal.

When providers place an imaging order, CareSelect Imaging Open Access will analyze and validate the appropriateness of the order against the latest clinical standards to provide an AUC consultation. An “appropriateness rating” is presented for the imaging order, along with a ranking of estimated costs and appropriate alternative imaging choices. Using this appropriateness information, the physician can make an informed decision about the imaging order and ensure completion of a digital consultation as required for PAMA. The results of these consultations should then be sent along with their order requisition forms.

CareSelect Imaging Open Access is fully qualified by CMS as a Clinical Decision Support Mechanism (CDSM). Its AUC content, which ordering physicians consult, is provided by CMS- qualified, provider-led entities including the American College of Radiology, the American College of Cardiology, the Society of Nuclear Medicine and Molecular Imaging, and the National Comprehensive Cancer Network. Access to this comprehensive criteria set helps ensure that clinical guidelines criteria are available for all Priority Clinical Areas outlined by CMS.

CareSelect Imaging Open Access is available to providers immediately. Providers can register at https://openaccess.careselect.org/registration.

National Decision Support Company, a Change Healthcare Company, offers CareSelect Clinical Decision Support and analytics solutions designed to influence clinician ordering to manage utilization and control costs while reducing administrative burden and streamlining the payer and provider data exchange. CareSelect Imaging is installed in over a thousand healthcare provider organizations.

For more information: changehealthcare.com

Related Content

The Candelis ImageGrid Plus PACS Server is an ultra-high-performance platform that can support high volume healthcare environments of 1,000 plus modalities
News | PACS | February 12, 2020
February 12, 2020 — The Candelis ImageGrid Plus...
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
CT image of Novel Coronavirus 2019-nCoV from the Radiology article showing a baseline CT image of a 75 year old male with multiple patchy areas of pure ground glass opacity (GGO) and GGO with reticular and/or interlobular septal thickening. Follow-up CT images on day 3 after admission show an overlap of organizing pneumonia with diffuse alveolar damage in that it is more diffuse and associated with underlying reticulation. Read more and see 15 more images from novel coronavirus patients in the article.

An image from the Radiology article showing a baseline CT image of a 75 year old male with multiple patchy areas of pure ground glass opacity (GGO) and GGO with reticular and/or interlobular septal thickening. Follow-up CT images on day 3 after admission show an overlap of organizing pneumonia with diffuse alveolar damage in that it is more diffuse and associated with underlying reticulation. Read more and see 15 more images from novel coronavirus patients in the article.

Feature | Computed Tomography (CT) | February 11, 2020
February 11, 2020 — The Radiological Society of North America (RSNA) jo
PaxeraHealth enterprise imaging, PACS, VNA solutions
News | Enterprise Imaging | February 11, 2020
February 11, 2020 — Enterprise Imaging developer PaxeraHealth
Carestream mobile Xray
News | Digital Radiography (DR) | February 08, 2020
February 8, 2020 — Carestream Health was awarded 37 new paten
An example of artificial intelligence (AI) being developed by Hitachi to automatically review and identify nodules on lung CT scans. This is part of a suite of AI apps Hitachi is developing. This example was being shown as a work in progress at RSNA 2019.

An example of artificial intelligence (AI) being developed by Hitachi to automatically review and identify nodules on lung CT scans. This is part of a suite of AI apps Hitachi is developing. This example was being shown as a work in progress at RSNA 2019. Photo by Dave Fornell.

Feature | Artificial Intelligence | February 07, 2020 | Sanjay Parekh, Ph.D. 
February 7, 2020 – At the 2019 Radiological Society...
Sponsored Content | Videos | Artificial Intelligence | February 07, 2020
At RSNA19, GE Healthcare introduced its...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.